Objectives, structure, resolution, and statutes
The Pan American Network for Drug Regulatory Harmonization (PANDRH) started in 1999, and its components are the Pan American Conference on Drug Regulatory Harmonization, the Steering Committee, the Secretariat, and the technical structures needed to implement projects in the agreed strategic areas.
The Pan American Network for Drug Regulatory Harmonization (PANDRH) is an initiative of the national regulatory authorities within the Region, and PAHO, that supports the processes of pharmaceutical regulatory harmonization in the Americas, within the framework of national and sub-regional health policies and recognizing pre-existing asymmetries.
- PANDRH's general objectives are to: Strengthen the regulatory functions and systems of the countries of the Region, promoting cooperation and sharing among countries, with the Pan American Health Organization (PAHO), and with other regional and international organizations, civil society, industry associations, and academia.
- Develop, approve and implement common proposals (projects, joint activities, technical documents, guidelines, work plans, etc.) for the regulation of health technologies, taking into account international guidelines and standards for regulatory convergence.
- Develop core competencies aimed at supporting and strengthening good regulatory practices and regulatory science in the Member States with the goal of achieving regulatory convergence in the Region. Encourage the NRAs of the Region to develop and maintain well-structured organizations to achieve effective regulatory functions as an essential part of health systems, in accordance.
- The Components of PANDRH are: The Pan American Conference on Drug Regulatory Harmonization (PANDRH), the Steering Committee (SC), the Technical Working Groups (WGs) in the areas considered as priority by the Conference, and the Secretariat.